SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001045969-03-001570
Filing Date
2003-05-14
Accepted
2003-05-14 17:03:51
Documents
2
Period of Report
2003-05-14
Items
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8K d8k.htm 8-K 14474
3 PRESS RELEASE DATED APRIL 23, 2003 dex991.htm EX-99.1 78871
  Complete submission text file 0001045969-03-001570.txt   94961
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 03699936
SIC: 2836 Biological Products, (No Diagnostic Substances)